Skip to content

ADXN

Addex Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$3.00
−0.17%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
2.26x
Price / sales
90.59x
Price / cash flow
-1.81x

Enterprise value

Enterprise value
$4.4M
EV / sales
76.09x
EV / EBITDA
-0.63x
EV / EBIT
-1.39x
Market cap
$5.3M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026